Presentation TCT 2023 TCT 431: Comparison of the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the Treatment of coronary In-Stent restenosis: the TIS-2 study. Presenter: Leos Pleva October 24, 2023
Presentation TCT 2023 TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons Presenter: Matthias Bossard October 24, 2023
Presentation TCT 2023 A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial Presenter: Patrick Serruys October 24, 2023
Presentation TCT 2023 Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population Presenter: Bruno Scheller October 24, 2023
Presentation TCT 2022 Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial Presenter: Christos Rammos September 17, 2022
Presentation TCT 2022 Have We Gotten to the Final Word on Paclitaxel Safety? Presenter: Eric Secemsky September 17, 2022
Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022
Presentation ARCH 2022 Paclitaxel or Limus: What is the Future in Drug Eluting Therapies? Presenter: Craig M. Walker April 23, 2022
Presentation ACC 2022 A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions Presenter: Alexandra Lansky April 04, 2022
Presentation TCT 2021 Have We Gotten to the Final Word on Paclitaxel Safety? Presenter: Eric Secemsky November 06, 2021
Presentation TCT 2021 One-year Outcomes of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions Presenter: Bruno Scheller November 06, 2021
Presentation TCT 2021 A Randomized Trial of Sirolimus-coated Versus Paclitaxel-coated Balloons in De Novo Coronary Lesions Presenter: Wan Azman Wan Ahmad November 06, 2021
Presentation TCT 2020 Where Are We With the Data on Paclitaxel? Presenter: Eric Secemsky October 18, 2020
Presentation TCT 2020 ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions Presenter: Andrew Holden October 18, 2020
Presentation TCT 2020 TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease Presenter: Brian Forrestal October 14, 2020
Presentation JIM 2020 Innovations in PCI: Update in Drug Coated Balloon Technologies(Focus on Paclitaxel Toxicity) Presenter: Juan Granada February 13, 2020
Presentation TCT Abstracts Posters 2019 Long-term Clinical Outcomes For All-comer Denovo Coronary Artery Lesions Treated With Paclitaxel-Coated Balloons Presenter: Nhung Nguyen October 08, 2019
Presentation TCT 2019 Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration Presenter: Robert Byrne September 28, 2019
Presentation TCT 2019 Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA? Presenter: Thomas Zeller September 27, 2019
Presentation TCT 2019 Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome Presenter: Piotr Buszman September 27, 2019